BRIDGEBIO PHARMA INC: Diferență între versiuni
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei BRIDGEBIO PHARMA INC listata cu simbolul US.BBIO ==Descriere companie== BridgeBio Pharma, Inc. (www.bridgebio.com)is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene therapy. The Company’s pipeline programs include product candidates ranging from early discovery to late-stage d...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 1: | Linia 1: | ||
Pagina dedicata companiei BRIDGEBIO PHARMA INC listata cu simbolul US.BBIO | Pagina dedicata companiei BRIDGEBIO [[PHARMA]] INC listata cu simbolul US.BBIO | ||
==Descriere companie== | ==Descriere companie== | ||
Versiunea curentă din 29 septembrie 2024 13:57
Pagina dedicata companiei BRIDGEBIO PHARMA INC listata cu simbolul US.BBIO
Descriere companie[edit | ]
BridgeBio Pharma, Inc. (www.bridgebio.com)is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene therapy. The Company’s pipeline programs include product candidates ranging from early discovery to late-stage development. The Company’s products include BBP-561, BBP-711, BBP-631 and BBP-454.
Grafic actiuni companie[edit | ]